Journal
MATERIALS
Volume 12, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/ma12101588
Keywords
nanomaterials; nanoparticles; nanobodies; brain cancer; blood-brain barrier; glioblastoma; nanodiagnostics; nanotherapy; nanomedicine
Categories
Funding
- Slovenian Research Agency (SRA) [P1-0390]
- SRA
- Bilateral project Slovenia-Russian Federation [BI-RU/19-20-005]
- Interreg EC Project 2014-2020 [146]
Ask authors/readers for more resources
Advances in technology of the past decades led to development of new nanometer scale diagnosis and treatment approaches in cancer medicine leading to establishment of nanooncology. Inorganic and organic nanomaterials have been shown to improve bioimaging techniques and targeted drug delivery systems. Their favorable physico-chemical characteristics, like small sizes, large surface area compared to volume, specific structural characteristics, and possibility to attach different molecules on their surface transform them into excellent transport vehicles able to cross cell and/or tissue barriers, including the blood-brain barrier. The latter is one of the greatest challenges in diagnosis and treatment of brain cancers. Application of nanomaterials can prolong the circulation time of the drugs and contrasting agents in the brain, posing an excellent opportunity for advancing the treatment of the most aggressive form of the brain cancerglioblastomas. However, possible unwanted side-effects and toxicity issues must be considered before final clinical translation of nanoparticles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available